CDK2 and breast cancer: Our results suggested that miR-885-3p could suppress the proliferation of breast cancer cells, partially by suppressing the expression levels of CDK2/CCNE1 and CDK4/6/CCND1 and arresting the cell cycle in the G0/G1 phase.